According to Plains GP's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 15.9118. At the end of 2022 the company had a P/E ratio of 14.5.
Year | P/E ratio | Change |
---|---|---|
2022 | 14.5 | -54.35% |
2021 | 31.7 | -1266.25% |
2020 | -2.72 | -128.68% |
2019 | 9.48 | -0.54% |
2018 | 9.53 | -300.94% |
2017 | -4.74 | -113.1% |
2016 | 36.2 | 102.43% |
2015 | 17.9 | -65.9% |
2014 | 52.4 | -77.89% |
2013 | 237 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.